Tratamiento de Cáncer de ovarios en Israel — obtenga 3 coincidencias personalizadas de clínicas

Patients can have their ovarian cancer diagnosis reviewed or re-tested in Israel. Leading centres specialise in histopathology revisions and molecular profiling. This process often corrects cancer subtypes and alters treatment plans. Experts at JCI-accredited facilities provide these reviews for international patients.

• Histopathology revision: Specialists re-examine existing biopsy slides to confirm the exact cancer subtype.
• Molecular profiling: Advanced labs test tissue for genetic markers to identify targeted therapies.
• Imaging review: Radiologists re-evaluate PET/CT and MRI scans using high-resolution diagnostic standards.
• Diagnostic speed: Major centres coordinate blood tests and scans within a 48-hour window.

Bookimed Expert Insight: Israeli oncology centres like Sheba Medical Center often include histopathology revision directly in their surgical packages. This is vital because a refined diagnosis can shift the surgical approach. Prof. Dan Grisaro at Sourasky has published over 80 scientific articles, reflecting the deep academic scrutiny applied to every case review.

Patient Consensus: Patients note that arranging a pathology review before travelling provides peace of mind. Experience in Israel shows that organising records and tissue blocks early ensures the appointment goes smoothly.

Innovative ovarian cancer treatments in Israel focus on advanced surgical techniques and precision medicine. Specialists utilise heated chemotherapy (HIPEC) combined with cytoreductive surgery to target microscopic cells. Robotic systems like DaVinci allow for minimally invasive tumor removal while preserving healthy tissue in complex abdominal cases.

• Hyperthermic chemotherapy: Surgeons circulate heated drugs directly in the abdomen during surgery.
• Robotic resection: The DaVinci system supports precise removal of complex gynaecological tumours.
• Advanced radiotherapy: VMAT and IMRT techniques deliver targeted radiation that spares organs.
• Maintenance therapies: Personalized management includes PARP inhibitors based on specific tumor biology.

Bookimed Expert Insight: Israel's leadership in oncology is driven by surgical volume and university-linked research. Specialists like Dr Almog Ben Yaacov at Sheba Medical Center have performed over 200 HIPEC procedures. This high volume often leads to better surgical outcomes for patients with advanced abdominal involvement.

Patient Consensus: Patients note that Israel offers fast access to multidisciplinary teams who prioritise total tumor removal. They emphasise that while intensive surgery requires significant recovery, the integration of detailed diagnostics like PET/CT helps specialists create more effective, personal treatment plans.

Top Israeli hospitals for ovarian cancer include Sheba Medical Center and Tel Aviv Sourasky Medical Center. These JCI-accredited facilities specialise in cytoreductive surgery and HIPEC. They utilise advanced genomic profiling and multidisciplinary tumour boards to tailor intensive treatment plans for complex stages.

• Sheba Medical Center: Largest Middle Eastern hospital ranking in Newsweek Top 10 globally.
• Sourasky Medical Center: Performs robotic-assisted surgeries with a reported 90% oncology success rate.
• Specialised leadership: Prof. Dan Grisaro at Sourasky heads the obstetrics and gynaecology department.
• Advanced technology: Centres offer brachytherapy, MRI-guided ultrasound, and innovative VMAT or SBRT radiation.

Bookimed Expert Insight: Israeli oncology centres often require a histopathology revision of your original biopsy slides. Data shows that specialists like Dr. Almog Ben Yaacov have performed over 200 HIPEC procedures. This high volume is why many Australian patients choose Israel for complex debulking surgery combined with heated chemotherapy.

Patient Consensus: Patients in Israel value having gynaecologic oncology teams and systemic treatments under one roof. They recommend re-reviewing all imaging at the clinic to ensure the most accurate surgical plan.

Leading ovarian cancer specialists in Israel include Prof. Dan Grisaro at Sourasky Medical Center and Dr Shira Felder at Sheba Medical Center. These JCI-accredited facilities offer advanced cytoreductive surgery and HIPEC. Most specialists hold international fellowships and treat thousands of patients annually.

• Surgical expertise: Prof. Dan Grisaro leads oncogynecology at Sourasky. He completed a fellowship in Canada.
• Radiation targets: Dr Shira Felder specialises in brachytherapy and SBRT at Sheba Medical Center.
• Tertiary care: Sheba Medical Center serves over 2 million patients annually. It is JCI-accredited.
• Academic leadership: Prof. Tamar Safra heads the Gynecological Oncology Service at Sourasky Medical Center.

Bookimed Expert Insight: Israeli oncology centres focus on high-volume surgical procedures like HIPEC to improve outcomes. Dr Almog Ben Yaacov at Sheba has performed over 200 HIPEC operations since 2018. This level of specific procedural volume often leads to higher success rates in complex cancer stages.

Patient Consensus: Patients value the multidisciplinary team approach and clear communication in Israeli clinics. They often suggest bringing original pathology slides and imaging records to ensure the specialist has all clinical history during the first consultation in Israel.

Israeli hospitals provide comprehensive logistics and language support to ensure a seamless medical journey for international patients. Major centres offer dedicated international departments. These units manage visa documents, airport transfers, hotel coordination, and professional medical translation for critical consultations and clinical paperwork.

• Logistics coordination: Specialist teams manage visa letters, flight scheduling, and local transit.
• Clinical translation: Doctors often train abroad. They communicate treatment plans in clear English.
• Hospital inclusions: Some packages, like those at Sheba Medical Center, include hotel stays.
• Airport services: Sourasky Medical Center offers transfers from the airport to the clinic.

Bookimed Expert Insight: While English is standard for doctors, nursing and administrative staff fluency can vary. Our data shows Sheba Medical Center manages over 2 million patients annually. Their scale supports robust multidisciplinary programs. Patients should confirm if packages include transfers. Some A$70,000+ packages include them, while others do not. This helps avoid unexpected local travel costs.

Patient Consensus: Patients note that coordinators at Sourasky Medical Center make doctor appointments run smoothly. It is helpful to have family assist with note-taking and management while in Israel.

Ovarian cancer doctors in Israel are highly trained specialists who often complete fellowships at leading centers like Memorial Sloan-Kettering and MD Anderson. Many hold dual board certifications in internal medicine and oncology, while others specialize exclusively in oncogynecology to provide targeted surgical and medical care.

• International fellowships. Dr. Tamar Sapra trained at Memorial Sloan-Kettering, a top cancer center in New York.
• Academic leadership. Dr. Dan Grisaro is a professor who completed specialized oncologic gynecology training in Toronto.
• Subspecialty focus. Dr. Shira Felder completed a fellowship at Princess Margaret Cancer Centre in Toronto.
• Research contributions. Dr. Ofer Merimsky is a senior investigator who has published extensively on complex cancers.

Bookimed Expert Insight: Israeli specialists often hold senior academic titles, which means they teach the next generation. For example, Dr. Dan Grisaro and Dr. Tamar Sapra are faculty at Tel Aviv University. This academic involvement ensures they use the newest protocols for ovarian cancer before they become widely available.

Patient Consensus: Patients feel most reassured when they see doctors who actively participate in clinical trials. They suggest checking for recent fellowships in North America to confirm the specialist uses the latest techniques. Many noted that having a surgeon and radiologist working together on one team is a sign of superior training.

Top ovarian cancer specialists in Israel include Dr. Ofer Merimsky and Dr. Tamar Sapra at Sourasky Medical Center, who provide advanced oncological care. Dr. Dan Grisaru and Dr. Shira Felder utilize specialized surgical and radiation techniques to treat complex gynecological malignancies with high precision.

• Dr. Ofer Merimsky. Deputy Director at Sourasky – specializes in complex cases and bone or soft tissue sarcomas.
• Dr. Dan Grisaru. Head of Obstetrics and Gynecology at Sourasky – trained in oncogynecology at University of Toronto.
• Dr. Tamar Sapra. Expert in oncological gynecology – holds dual specialization in clinical oncology and radiotherapy for planning.
• Dr. Shira Felder. Head of Gynecologic Oncology Service at Sheba – focuses on precision radiation therapy and brachytherapy.

Bookimed Expert Insight: Patients seeking treatment in Tel Aviv often find a concentration of expertise at Sourasky Medical Center. Doctors there, such as Dr. Dan Grisaru and Dr. Ofer Merimsky, have published over 100 research papers combined. This suggests their treatment methods are heavily influenced by the latest clinical research rather than just standard practice.

Patient Consensus: Patients emphasize choosing a specialist who coordinates the entire journey from surgery to pathology. Seeing a dedicated gynecologic oncologist rather than a general gynecologist is vital for cancer surgery. Real experiences show that a clear treatment timeline and a reliable second opinion provide the most reassurance.

Israeli oncologists provide expert second opinions on ovarian cancer through high-level specialists like Dr. Ofer Merimsky. These reviews often focus on pathology revision and precision treatment planning. Many senior experts at JCI-accredited centers like Sourasky Medical Center offer remote telemedicine consultations to patients worldwide.

• Pathology revision. Specialists re-examine original biopsy slides to confirm the exact tumor subtype.
• Molecular profiling. Doctors like Dr. Tamar Jablonski-Perec analyze tumor biology for targeted therapy eligibility.
• Advanced imaging review. Experts evaluate PET/CT and MRI scans to refine staging and surgical plans.
• Clinical trial access. Dr. Irina Stepfansky assesses if patients qualify for innovative phase I-III trials.

Bookimed Expert Insight: A second opinion in Israel often shifts from general oncology to narrow sub-specialization. Dr. Tamar Sapra, for example, holds dual certification in medical and radiation oncology. This allows her to provide a unified treatment plan in one consultation, which is rare. Patients often save time by avoiding separate appointments for chemo and radiation planning.

Patient Consensus: Patients often seek these reviews because they want reassurance before starting major surgery or chemotherapy. They noticed that a specialist cancer center provides much more detailed insights than a general oncologist. Most find that receiving a clear timeline and confirmed diagnosis from an expert gives them much needed confidence.